HER2-Targeted gene transfer

Human Gene Therapy

Volumn 8, Issue 6, 1997, Pages 719-727

  Foster, Brian J ^a   Kern, Jeffrey A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY CONJUGATE; CHLOROQUINE; EPIDERMAL GROWTH FACTOR RECEPTOR; LUCIFERASE; MEMBRANE ENZYME; PHOSPHOTRANSFERASE; POLYLYSINE;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL STRAIN 3T3; CONTROLLED STUDY; DNA DRUG COMPLEX; EPITHELIUM TUMOR; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; MOUSE; NONHUMAN; ONCOGENE NEU; PROTEIN EXPRESSION;

EID: 0030970939     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.6-719     Document Type: Article

References (46)

1. HER2 monoclonal antibody in patients with HER2/neu-over-expressing metastatic breast cancer. J. Clin. Oncol. 14, 737-744.
2. BATRA, R.K., WANG-JOHANNING, F., WAGNER, E., GARVER, R., and CURIEL, D.T. (1994). Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther. 1, 255-260.
3. BAULIDA, J., KRAUS, M.H., ALIMANDI, M., DI FIORE, P.P., and CARPENTERK, G. (1996). All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271, 5251-5257.
4. HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 89, 4285-1289.
5. CHEN, J., GAMOU, S., TAKAYANAGI, A., and SHIMIZU, N. (1994). A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 338, 167-169.
6. COTTEN, M., WAGNER, E., and BIRNSTIEL, M. (1993). Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol. 27, 619-644.
7. COUSSENS, L., YANG-FENG, T.L., LIAO, Y-C., CHEN, E., GRAY, A., McGRATH, J., SEEBURG, P.H., LIBERMANN, T.A., SCHLESSINGER, J., FRANCK, U., LEVINSON, A., and ULLRICH, A. (1985). Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1139.
8. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. DE SANTES, K., SLAMON, D., ANDERSON, S.K., SHEPARD, M., FENDLY, B., MANEVAL, D., and PRESS, O. (1992). Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res. 52, 1916-1923.
10. DESHANE, J., LOECHEL, F., CONRY, R.M., SIEGAL, G.P., KING, C.R., and CURIEL, D.T. (1994). Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferation effect in erbB2 over-expressing cancer cell lines. Gene Ther. 1, 332-337.
11. DREBIN, J.A., LINK, V.C., GREENE, M.I. (1988). Monoclonal antibodies specific for the neu oncogene product directly mediate antitumor effects in vivo. Oncogene 2, 387-394.
12. 1. Cancer Res. 54, 5171-5177.
13. FENDLY, B.M., WINGET, M., HUDZIAK, R.M., LIPARI, M.T., NAPIER, M.A., and ULLRICH, A. (1990). Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/NEU gene product. Cancer Res. 50, 1550-1558.
14. HALL, P.A., HUGHES, C.M., STADDON, S.L., RICHMAN, P.A., GULLICK, W.J., and LEMOINE, N.R. (1990). The c-erbB-2 proto-oncogene in human pancreatic cancer. J. Pathol. 161, 195-200.
15. HARPOLE, D.H., HERNDONE, J.E., WOLFE, W.A., IGLEHART, J.D., and MARKS, J.R. (1995). A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 55, 51-56.
16. HAYRES, M., GARRETT, R.A., GRATZER, W.B. (1970). Structure of nucleic acid-poly base complexes. Biochemistry 9, 4410-4416.
17. HUDZIAK, R.M., SCHLESSINGER, J., and ULLRICH, A. (1987). Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84, 7159-7163.
18. HUDZIAK, R.M., LEWIS, G.D., WINGET, M., FENDLY, B.M., SHEPARD, H.M., and ULLRICH, A. (1989). p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitized human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9, 1165-1172.
19. IWAMOTO, G.K., MONICK, M.M., CLARK, B.D., AURON, P.E., STINSKI, M.F., and HUNNINGHAKE, G.W. (1990). Modulation of interleukin-1 beta gene expression by the immediate early genes of human cytomegalovirus. J. Clin. Invest. 85, 1853-1857.
20. KANG, Y., and PARDRIDGE, W.M. (1994). Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. J. Pharmacol. Exp. Therapeut. 269, 344-350.
21. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 50, 5184-5191.
22. HER2 antibody. Am. J. Respir. Cell Mol. Biol. 9, 448-454.
23. KERN, J.A., SLEBOS, R., TOP, B., RODENHUIS, S., LAGER, D., ROBINSON, R.A., WEINER, D., and SCHWARTZ, D.A. (1994). C-erbB2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest. 93, 516-520.
24. LAEMLI, U.K. (1975). Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. Proc. Natl. Acad. Sci. USA 72, 4288-4292.
25. LEAMON, C.P., and LOW, P.S. (1993). Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem. J. 291, 855-860.
26. LEMOINE, N.R., JAIN, S., SILVESTRE, F., LOPES, C., HUGHES, C.M., McLELLAND, E., GULLICK, W.J., and FILIPE, M.I. (1991). Amplification and over-expression of the EGF receptor and c-erbB-2 oncogenes in human stomach cancer. Br. J. Cancer 64, 74-83.
27. LOZIER, J.N., THOMPSON, A.R., HU, P., READ, M., BRINKHOUS, K.M., HIGH, K.A., and CURIEL, D.T. (1994). Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes. Hum. Gene Ther. 5, 313-322.
28. MOORE, S., and STEIN, W.H. (1963). Chromatographic determination of amino acids by the use of automatic recording equipment. Methods Enzymol. 6, 819-831.
29. MULLER, W.J., SINN, E., PATTINGALE, P.K., WALLACE, R., and LEDER, P. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115.
30. NISHIMURA, T., NAKAMURA, Y., TSUKAMOTO, H., TAKEUCHI, Y., TOKUDA, Y., IWASAWA, M., YAMAMOTO, T., MASUKO, T., HASHIMOTO, Y., and HABU, S. (1992). Human c-erb B-2 moto-oncagene product as a target for biospecific-antibody-directed adaptive tumor immunotherapy. Int. J. Cancer 50, 800-804.
31. NOGUCHI, M., MURAHAMI, M., BENNETT, W., LUPU, R., HUI, R. HARRIS, C.C., and GERWIN, B.I. (1993). Biologic consequences of over-expression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res. 53, 2035-2043.
32. HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 92, 1327-1331.
33. PIETRAS, R.J., FENDLY, B.M., CHAZIN, V.R., PEGRAM, M.D., HOWELL, S.B., and SLAMON, D.J. (1994). Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene 9, 1829-1838.
34. PRESS, M.F., CORDON-CARDO, C., and SLAMON, D.J. (1990). Expression of the HER2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5, 953-962.
35. SCHECHTER, A.L., STERN, D.F., VAIDYANATHAN, L., DECKER, S.J., DREBIN, J.A., GREENE, M.I., and WEINBERG, R.A. (1984). The neu oncogene: An erbB-2 related gene encoding a 184,000-Mr tumor antigen. Nature 312, 513-516.
36. SLAMON, D.J., CLARK, G.M., WONG, S.C., LEVIN, W.J., ULLRICH, A., and McGUIRE, W.L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
37. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.C., KEITH, D.E., LEVIN, W.J., STUART, S.C., UDOVE, J., ULLRICH, A., and PRESS, M.F. (1989). Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244, 707-712.
38. SMYTHE, W.R., HWANG, H.C., KUNJLATA, M.A., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, J.M., and ALBELDA, S.M. (1994). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtK) gene to thoracic neoplasms: An effective in vitro drug sensitization system. Cancer Res. 54, 2055-2059.
39. TATEISHI, M., ISHIDA, T., MITSUDOMI, T., KANEKO, S., and SUGIMACHI, K. (1991). Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur. J. Cancer 27, 1372-1375.
40. WAGNER, E., ZENKE, M., COTTEN, M., BEUG, H., and BIRNSTIEL, M.L. (1990). Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA 87, 3410-3414.
41. WAGNER, E., COTTEN, M., MECHTLER, K., KIRLAPPOS, H., and BIRNSTIEL, M.L. (1991). DNA-binding transferrin conjugates as functional gene-delivery agents: Synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjugate Chem. 2, 227.
42. WAGNER, E., ZATLOUKAL, K., COTTEN, M., KIRLAPPOS, H., MECHTLER, K., CURIEL, D.T., and BIRNSTIEL, M.L. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89, 6099-6103.
43. neu) in human non-small cell carcinomas of the lung. Cancer Res. 50, 421-425.
44. 1. Cancer Res. 53, 94-100.
45. WU, G.Y., ZHAN, P., SZE, L., ROSENBERG, A.R., and WU, C.H. (1994). Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J. Biol. Chem. 269, 11542-11546.
46. YAMAMOTO, T., IKAWA, S., AKIYAMA, T., SEMBA, K., NOMURA, N., NOBUYUKI, M., SAITO, T., and TOYOSHIMA, K. (1986). Similarity of protein encoded by the human c-erbB-2 gene to the epidermal growth factor receptor. Nature 319, 230-234.